| |
| |
|
| Insider
Information: |
Barnes Alane P |
| Relationship: |
Chief Legal Officer |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
300,762 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,930,892 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
300,762 |
|
|
| Total
Value |
$1,930,892 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 14.9%
|
27.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Chief Legal Officer |
2024-05-13 |
300,762 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
44 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• – – |
2013-07-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
41,931 |
|
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2014-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
27,000 |
81,487 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2015-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,800 |
77,033 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Legal Officer |
• • – |
2021-12-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
55,000 |
201,969 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Legal Officer |
• • – |
2021-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
221,969 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Legal Officer |
• • – |
2022-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
34,000 |
232,770 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Legal Officer |
• • – |
2023-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
64,000 |
300,036 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2016-03-01 |
4 |
D |
$2.13 |
$1,463 |
D/D |
(687) |
85,416 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2018-01-01 |
4 |
D |
$4.91 |
$2,254 |
D/D |
(459) |
79,090 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Senior VP, Chief Legal Officer |
• • – |
2019-01-01 |
4 |
D |
$8.07 |
$3,414 |
D/D |
(423) |
77,530 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2017-01-01 |
4 |
D |
$6.33 |
$8,109 |
D/D |
(1,281) |
78,096 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2018-01-20 |
4 |
D |
$5.59 |
$10,962 |
D/D |
(1,961) |
77,129 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2015-03-01 |
4 |
D |
$10.20 |
$11,424 |
D/D |
(1,120) |
71,876 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2014-03-01 |
4 |
D |
$11.69 |
$12,742 |
D/D |
(1,090) |
81,182 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2016-01-01 |
4 |
D |
$10.32 |
$13,220 |
D/D |
(1,281) |
68,288 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Chief Legal Officer |
• • – |
2023-12-19 |
4 |
D |
$6.05 |
$15,016 |
D/D |
(2,482) |
293,539 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2017-01-20 |
4 |
D |
$5.95 |
$15,464 |
D/D |
(2,599) |
75,497 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2014-01-14 |
4 |
OE |
$1.20 |
$16,200 |
D/D |
13,500 |
55,978 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2014-01-14 |
4 |
D |
$10.87 |
$16,207 |
D/D |
(1,491) |
54,487 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2018-05-15 |
4 |
OE |
$1.42 |
$17,750 |
D/D |
12,500 |
98,268 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2018-05-15 |
4 |
D |
$5.91 |
$17,754 |
D/D |
(3,004) |
95,264 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2014-01-01 |
4 |
D |
$7.60 |
$18,643 |
D/D |
(2,453) |
42,478 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2016-01-20 |
4 |
D |
$7.55 |
$19,622 |
D/D |
(2,599) |
65,689 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2018-02-28 |
4 |
OE |
$3.26 |
$21,871 |
D/D |
6,709 |
85,768 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
VP, General Counsel & Corp Sec |
• • – |
2015-01-20 |
4 |
D |
$11.17 |
$24,686 |
D/D |
(2,210) |
72,370 |
0 |
- |
|
44 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
